ArticleThe Biochemical journal2026
Structural organization of TAM receptor ectodomains.
Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural basis of phosphatidylserine enhancement of Gas6 ligand-induced Axl activation.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
TYRO3, AXL, and MERTK, the TAM receptor tyrosine kinases (RTKs), play roles in phagocytosis and negative regulation of immune responses, contributing to homeostasis in many adult tissues. Aberrant TAM signaling leads to diseases including autoimmune disorders, viral infection, inflammation, and cancer. Development of successful drugs targeting TAM receptors is hindered by incomplete knowledge of the receptor activation mechanism. Receptor dimerization is assumed to play a role, as seen for most RTKs. However, full biological responses require the TAM ligands to engage phosphatidylserine in an opposing cell or virus membrane, suggesting a more complex mechanism, possibly involving higher-order receptor oligomerization or clustering. Here, we present an X-ray crystal structure of the ectodomain of MERTK, which adopts a highly curved conformation with key interdomain boundaries stabilized by N-linked glycan moieties. We show that this MERTK extracellular region (ECR) forms a similar conformation in solution using small-angle X-ray scattering (SAXS), which also suggests a flexible ECR. We compare these crystallographic and solution data for MERTK with SAXS and AlphaFold structural predictions for the other two TAM receptors. SAXS data confirm that each TAM ECR has a distinct curvature, with TYRO3 the most bent and AXL relatively straight. This leads us to speculate that these different ectodomain conformations guide receptor-specific functions. The MERTK X-ray crystal structure also suggests a head-to-tail intermolecular interaction between the Ig2 domain of one MERTK and the FNIIIb domain of a second that has intriguing parallels with interactions that have been proposed to regulate Eph receptor clustering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.